Cryoxtract Instruments, a Leading Provider of Automated Solutions for Preserving and Optimizing Frozen Biological Samples, Appoints Veteran John A. McCarthy, Jr. as CEO to Drive Commercial and Corporate Growth  
12/5/2012 10:16:08 AM

WOBURN, Mass.--(BUSINESS WIRE)--CryoXtract Instruments, LLC, a leader in developing unique automation solutions for preserving and optimizing frozen biological samples, announced today that John A. McCarthy, Jr. has joined CryoXtract as Chief Executive Officer to drive its broad commercial plans, including important strategic partnership opportunities. Mr. McCarthy is a highly seasoned executive having led the transformational growth of numerous science- and technology-based companies over the past twenty years from early-stage organizations into successful commercial entities, both in the private and public markets. Mr. McCarthy’s track record includes successfully raising over $1 billion of capital across the capital markets, as well as developing, executing and managing numerous precedent-setting strategic corporate partnerships. CryoXtract has developed and is commercializing a unique fully automated technology platform that enables the aliquotting of frozen biosamples critical to the advancement of molecular medicine, biomarker discovery/validation and other important R&D initiatives, while preserving the biosamples in a -80oC environment throughout the entire process. In May 2012, the International Society for Biological and Environmental Biorepositories (ISBER) awarded its prestigious Outstanding New Product Award to the Company’s CXT 750 Frozen Sample Aliquotter.